FDA
Cisatracurium Besylate
The FDA lists this product in 30 strengths and forms.
Composition
- Active ingredients
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA212432-001 · Prescription
- CISATRACURIUM BESYLATE EQ 10MG BASE/ML · InjectableANDA212432-002 · Prescription
- CISATRACURIUM BESYLATE EQ 10MG BASE/ML · InjectableANDA215516-002 · Prescription
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA215516-003 · Prescription
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA215516-001 · Prescription
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA216538-001 · Discontinued
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA201851-001 · Prescription
- CISATRACURIUM BESYLATE EQ 10MG BASE/ML · InjectableANDA203078-002 · Prescription
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA203078-001 · Prescription
- CISATRACURIUM BESYLATE EQ 2MG BASE/ML · InjectableANDA203079-001 · Prescription
- CISATRACURIUM BESYLATE EQ 10MG BASE/ML · Injectable
At a glance
- Brand name
- Cisatracurium Besylate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Caplin
- Status
- Prescription
- FDA approval
- 9 Jun 2023
- Application
- ANDA217725-001